Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03538860 · ClinicalTrials.gov registry record · NA

Validation of an Automated Online Language Interpreting Tool - Phase Two.

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
114
Enrollment target

NCT03538860 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 114 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03538860, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
114 participants
Enrollment target

Study Summary

There is a pressing national need to provide higher-quality, more effectively accessible language interpretation services to improve the health outcomes of Americans who have limited English proficiency (LEP). This project addresses a critical component of this problem: The need to improve access to high quality, mental health services for diverse populations by improving the flow of clinical work across care settings (primary care and specialty care) through the use of innovative online asynchronous methods of language interpretation and clinical communication. The investigators are conducting a two phase study. The first phase is completed and involved developing and testing the interpreting tool. The second phase of the research is a clinical trial to compare two methods of cross-language psychiatric assessment.

Interventions

  • BEHAVIORAL Active comparator: Human interpreter
  • BEHAVIORAL Intervention: Asynchronous Telepsychiatry

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2017-11-14
Est. Completion 2021-07-31
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03538860

The ClinicalTrials.gov registry entry for NCT03538860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Active comparator: Human interpreter is the first listed.

NCT03538860 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03538860 about?

NCT03538860 is a clinical study titled "Validation of an Automated Online Language Interpreting Tool - Phase Two.". There is a pressing national need to provide higher-quality, more effectively accessible language interpretation services to improve the health outcomes of Americans who have limited English proficiency (LEP). This project addresses a critical component of this problem: The need to improve access to...

What is the current status of trial NCT03538860?

This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2017-11-14. Estimated completion is 2021-07-31.

What interventions are being tested in trial NCT03538860?

The interventions under investigation include: Active comparator: Human interpreter (BEHAVIORAL), Intervention: Asynchronous Telepsychiatry (BEHAVIORAL).

Who is sponsoring clinical trial NCT03538860?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.